A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

Researchers evidence suggests it’s the lessening of amyloid-beta in the brain that is behind cognitive decline.

In the past two years, the U.S. Food and Drug Administration has approved two monoclonal antibody treatments to slow ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, ...

This year's World Alzheimer's Day campaign aims to address the stigma and discrimination while highlighting global efforts to ...

Much of the brain is made up of a constellation of star-shaped cells called astrocytes, which play vital roles in immunity, ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

The scientists looked at two brain scans and found that areas with more amyloid-beta showed increased brain activity, with ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...